Inspire Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Inspire Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,577	Closed	-$198K	–	489
2024 Q1	$198K	Sell	12,577 -731	-5%	-$11.3K	0.03%	337
2023 Q4	$215K	Buy	+13,308	New	+$170K	0.03%	283

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Inspire Advisors's DCPH Position: Q2 2024 in Review

Inspire Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 12,577 shares — an estimated $198K sold.

Inspire Advisors first reported a position in DCPH in Q4 2023 and held it in 2 quarters. The position peaked at $215K in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Inspire Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Inspire Advisors sold 12,577 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $198K.
Inspire Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Inspire Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $215K in Q4 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Inspire Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.